 HENDERSON, NV ACCESSWIRE June 28, 2021 United Health Products, Inc. OTCPK:UEEC, UHP, developer, manufacturer and marketer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose hemostatic agent, today provided a corporate update on its current product development and commercialization activities. In anticipation of a successful outcome to its Class III Pre-market Approval PMA application, the UHP team is pursuing several initiatives that will maximize the addressable market for its HemoStyp gauze and additional formats which, if approved by the FDA, will allow UHP to offer a full suite of Class III hemostatic formats to the human surgical market. 